Trevena Inc. (NASDAQ: TRVN)
$2.4650
+0.8450 ( +2.28% ) 275.8K
Trevena Inc is an American biopharmaceutical company focused on developing and commercializing novel medicines for patients affected by central nervous system, or CNS, disorders.
Market Data
Open
$2.4650
Previous close
$1.6200
Volume
275.8K
Market cap
N/A
Day range
$2.1260 - $3.0200
52 week range
$1.1300 - $19.2275
SEC Filings
| Form Type | Description | Pages | Date |
|---|---|---|---|
| 4 | Insider transactions | 1 | Sep 17, 2024 |
| 8-k | 8K-related | 13 | Aug 30, 2024 |
| 10-q | Quarterly Reports | 69 | Aug 08, 2024 |
| 8-k | 8K-related | 14 | Aug 08, 2024 |
| 8-k | 8K-related | 16 | Aug 08, 2024 |
| 8-k | 8K-related | 14 | Jul 08, 2024 |
| 8-k | 8K-related | 13 | Jun 18, 2024 |
| 4 | Insider transactions | 1 | Jun 17, 2024 |
| 4 | Insider transactions | 1 | Jun 14, 2024 |
| 4 | Insider transactions | 1 | Jun 14, 2024 |